These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
3. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation. Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514 [TBL] [Abstract][Full Text] [Related]
4. Current Use and Trends in Hematopoietic Cell Transplantation in the United States. D'Souza A; Lee S; Zhu X; Pasquini M Biol Blood Marrow Transplant; 2017 Sep; 23(9):1417-1421. PubMed ID: 28606646 [TBL] [Abstract][Full Text] [Related]